AuntMinnie

MARCH 7, 2024

In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging.

PET Scan 115

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 115

Imaging Technology

JUNE 10, 2024

Urbain, MD, PhD, FASNC, professor of Radiology/Nuclear Medicine and Medicine, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As

Nuclear Medicine 59

Nuclear Medicine Radiopharmaceuticals Hospital Health Science 59

AuntMinnie

JUNE 9, 2024

Jean-Luc Urbain, MD, PhD, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Urbain, a professor of radiology and nuclear medicine, has served in multiple roles within SNMMI, in addition to his most recent post as vice president-elect. Jean-Luc Urbain, MD, PhD. “As

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Government Education 40

TTG Imaging Solutions

MAY 5, 2023

operates a diagnostic imaging turnkey business and serves as an OEM and service provider for a well-respected portfolio of fixed and mobile solid-state nuclear medicine cameras. Digirad has provided unique solutions to hospitals and outpatient providers for more than two decades. Digirad Health, Inc.

Imaging 52

Imaging Radiopharmaceuticals Radiation Oncology Nuclear Medicine 52

Future Teleradiology

NOVEMBER 21, 2023

Teleradiology & Radiology data for artificial intelligence (AI) Introduction: Nuclear medicine, a dynamic and rapidly evolving field, continues to break new ground in diagnostic and therapeutic approaches. Introduction to Nuclear Medicine: Merging Physics and Medicine: Provide an overview of nuclear medicine.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Teleradiology 52

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 82

Medical Radiopharmaceuticals Pharmaceutical Radiation 82